Arkema Tidigare resultatutveckling
Tidigare kriterier kontrolleras 0/6
Arkema s intäkter har minskat med en genomsnittlig årlig takt på -39%, medan Chemicals -branschen såg intäkter på växande på 7.4% årligen. Intäkterna har varit fallande med en genomsnittlig takt på 0.8% per år. Arkema s avkastning på eget kapital är 0.6% och den har en nettomarginal på 0.2%.
Viktig information
-39.02%
Tillväxttakt i vinsten
-38.87%
Tillväxttakt för EPS
| Chemicals Tillväxt i branschen | 10.42% |
| Intäkternas tillväxttakt | -0.81% |
| Avkastning på eget kapital | 0.56% |
| Nettomarginal | 0.19% |
| Nästa resultatuppdatering | 30 Jul 2026 |
Senaste uppdateringar av tidigare prestationer
Analysartikel • May 18
Some May Be Optimistic About Arkema's (EPA:AKE) Earnings
Soft earnings didn't appear to concern Arkema S.A.'s ( EPA:AKE ) shareholders over the last week. We think that the...Analysartikel • Nov 16
There May Be Reason For Hope In Arkema's (EPA:AKE) Disappointing Earnings
Arkema S.A.'s ( EPA:AKE ) stock was strong despite it releasing a soft earnings report last week. We think that...Recent updates
Uppdatering av berättelse • May 20
AKE: Battery Materials Expansion And Mixed Ratings Will Shape Balanced Future Prospects
Arkema's analyst price target nudged higher by about €2 to €63.88 as analysts updated their models to reflect revised assumptions for revenue growth, profit margins, discount rates and future P/E multiples following a mix of recent upgrades, downgrades and modest target increases. Analyst Commentary Recent research on Arkema presents a mixed picture, with some analysts lifting price targets or ratings and others turning more cautious.Analysartikel • May 18
Some May Be Optimistic About Arkema's (EPA:AKE) Earnings
Soft earnings didn't appear to concern Arkema S.A.'s ( EPA:AKE ) shareholders over the last week. We think that the...
Uppdatering av berättelse • Apr 30
AKE: Battery Materials Expansion Will Support Future Rerating Potential
Arkema's analyst fair value estimate has moved slightly higher to about €81.56, reflecting analysts' updated assumptions on revenue growth, profit margins, and future P/E in light of recent upgrades, downgrades, and modest price target increases from several banks. Analyst Commentary Recent Street research on Arkema is mixed, but there is a clear cluster of more constructive calls that help frame how supportive analysts currently see the risk and reward around the stock.
Uppdatering av berättelse • Apr 15
AKE: Battery Expansion And Margin Execution Will Constrain Future Re Rating Potential
Arkema's fair value estimate has shifted from €44.00 to €50.00 as analysts factor in updated assumptions on revenue growth, profit margins and future P/E multiples, in line with a recent series of higher price targets and rating changes across major research firms. Analyst Commentary Recent Street research on Arkema presents a mixed picture, with several higher price targets sitting alongside at least one downgrade and more restrained views on upside.Uppdatering av berättelse • Apr 01
AKE: Battery Capacity Push Will Face Execution Risk And Uncertain Earnings Trajectory
Analysts have nudged Arkema's average price target higher to around €60 to €65, citing recent target increases from several banks and mixed rating changes that reflect a more balanced view on growth, margins, and a higher assumed future P/E multiple. Analyst Commentary Recent research has given Arkema a more mixed backdrop, with some banks lifting price targets while others turn more cautious on the shares, despite keeping targets within a relatively tight €60 to €65 range.Uppdatering av berättelse • Mar 18
AKE: Battery Materials Expansion And Mixed Ratings Will Shape Future Rerating
Arkema's analyst price target has edged up by €0.13 to €61.88, reflecting a blend of higher fair value P/E assumptions and mixed rating actions from analysts who have recently adjusted targets between €60 and €65. Analyst Commentary Bullish Takeaways Bullish analysts are comfortable assigning price targets in the €62 to €65 range, which supports the current blended target of €61.88 and signals confidence that Arkema can justify a slightly higher P/E than previously assumed.Uppdatering av berättelse • Mar 04
AKE: Battery Materials Expansion And Decarbonization Efforts Will Support Future Rerating
Our analyst price target for Arkema shifts from €65.06 to €61.88 as analysts factor in recent downgrades and lower external price targets, along with updated assumptions for revenue growth, profit margins and future P/E multiples. Analyst Commentary Recent Street research on Arkema has been mixed, with both upgrades and downgrades sitting alongside reduced price targets.Uppdatering av berättelse • Feb 17
AKE: Battery Materials And Specialty Polymers Will Support Re Rating
Arkema's analyst price target has shifted from €85.00 to €80.00, as analysts factor in slightly softer assumptions on revenue growth, profit margins and future P/E, even as recent research updates include both an upgrade and a separate €5 adjustment to targets. Analyst Commentary Recent research on Arkema sends a mixed but broadly constructive signal, with the latest changes in price targets and ratings pointing to a more nuanced view of the company’s risk and reward profile.Analysartikel • Feb 13
After Leaping 26% Arkema S.A. (EPA:AKE) Shares Are Not Flying Under The Radar
The Arkema S.A. ( EPA:AKE ) share price has done very well over the last month, posting an excellent gain of 26%. Not...Uppdatering av berättelse • Feb 03
AKE: Battery Expansion Will Face Tougher Sector Backdrop And Execution Risk
Analysts have trimmed their price target on Arkema by €5, reflecting softer revenue growth assumptions, a slightly lower future P/E multiple, and sector headwinds highlighted in recent research, while keeping fair value broadly unchanged. Analyst Commentary Recent research points to a more cautious tone around Arkema, with pricing assumptions and sector views putting some pressure on sentiment.Uppdatering av berättelse • Jan 20
AKE: Battery Materials Expansion Will Face Tougher Sector Backdrop And Execution Risk
Narrative update Analysts have trimmed their price target on Arkema by €3 to €44, reflecting a lower fair value estimate along with updated views on revenue growth, margins and a reduced future P/E multiple, following recent cautious research on European chemicals and ingredients groups. Analyst Commentary Street research on Arkema has turned more cautious, with bearish analysts trimming price targets and flagging risks around growth visibility and valuation.Uppdatering av berättelse • Jan 06
AKE: Battery Materials Push Will Support Re Rating Despite Sector Downgrade
Analysts have trimmed their fair value estimate for Arkema to €85 from €95. This reflects lower assumed revenue growth, a slightly softer profit margin profile, a higher discount rate and more conservative future P/E expectations following recent cuts to Street price targets and a sector downgrade.Uppdatering av berättelse • Dec 21
AKE: Battery Materials Push Will Confront Tougher Sector Backdrop Ahead
The analyst fair value estimate for Arkema has been reduced from EUR 56 to EUR 47 as analysts factor in a higher discount rate, weaker revenue growth expectations, softer profit margins, and a sector wide shift toward more favored industrial gases and specialty distributors. Analyst Commentary Recent Street research reflects a more cautious stance on Arkema, with several bearish analysts trimming price targets and, in at least one case, reducing their rating.Uppdatering av berättelse • Dec 07
AKE: Sustainability And Decarbonization Investments Will Drive Future Rerating Despite Recent Downgrade
Arkema's analyst price target has been trimmed by about EUR 1 to EUR 65.06 as analysts factor in slightly softer long term growth and margin expectations, alongside a wave of recent price target cuts and a fresh Underweight rating from the Street. Analyst Commentary Recent Street research presents a mixed picture for Arkema, with several price target cuts but divergent views on the company’s medium term execution and earnings power.Uppdatering av berättelse • Nov 23
AKE: Recent Downgrade Will Be Offset By Sustainability Actions And Emissions Reductions
Analysts have lowered the fair value estimate for Arkema from €70.63 to €66.06, citing cautious sector sentiment and a series of reduced price targets across the chemical industry. Analyst Commentary Analysts continue to reassess Arkema's prospects in response to both company-specific and broader sector developments.Analysartikel • Nov 16
There May Be Reason For Hope In Arkema's (EPA:AKE) Disappointing Earnings
Arkema S.A.'s ( EPA:AKE ) stock was strong despite it releasing a soft earnings report last week. We think that...Analysartikel • Nov 12
Arkema S.A. (EPA:AKE) Just Reported, And Analysts Assigned A €66.94 Price Target
Investors in Arkema S.A. ( EPA:AKE ) had a good week, as its shares rose 6.6% to close at €52.60 following the release...Uppdatering av berättelse • Nov 06
AKE: Operational Improvements And Sustainability Efforts Will Drive Future Upside
The consensus analyst price target for Arkema has been reduced notably in recent updates, with targets now ranging from EUR 55 to EUR 80. Analysts cite cautious expectations for revenue growth and refining profit margin assumptions as reasons for the adjustment.Uppdatering av berättelse • Oct 23
Analysts Revise Arkema Price Target Lower Amid Cautious Optimism and Recent Sustainability Initiatives
Arkema's analyst price target has been revised downward from €72.75 to €70.63. This change reflects recent analyst adjustments driven by lower growth and profit expectations.Uppdatering av berättelse • Oct 09
New Capacity And R&D Focus Will Accelerate Renewable Transition
Arkema's analyst price target has been revised downward from €76.06 to €72.75. This change reflects analysts' expectations for slower revenue growth and a higher discount rate, even though profit margins have seen slight improvement.Uppdatering av berättelse • Sep 25
New Capacity And R&D Focus Will Accelerate Renewable Transition
Analysts have trimmed Arkema’s price target to €76.06, reflecting heightened caution around 2025 guidance cuts, persistent margin pressure, and weaker end-market demand, despite some confidence in the company’s long-term positioning. Analyst Commentary Bearish analysts cite increased risk of significant 2025 guidance cuts, particularly ahead of Q2 results.Analysartikel • Aug 27
Is It Too Late To Consider Buying Arkema S.A. (EPA:AKE)?
While Arkema S.A. ( EPA:AKE ) might not have the largest market cap around , it received a lot of attention from a...Analysartikel • Aug 06
Arkema S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Arkema S.A. ( EPA:AKE ) shareholders are probably feeling a little disappointed, since its shares fell 6.5% to €58.65...Analysartikel • Jul 27
These 4 Measures Indicate That Arkema (EPA:AKE) Is Using Debt Reasonably Well
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analysartikel • Jul 05
Potential Upside For Arkema S.A. (EPA:AKE) Not Without Risk
There wouldn't be many who think Arkema S.A.'s ( EPA:AKE ) price-to-earnings (or "P/E") ratio of 15.1x is worth a...Analysartikel • May 23
Arkema (EPA:AKE) Is Increasing Its Dividend To €3.60
Arkema S.A. ( EPA:AKE ) will increase its dividend from last year's comparable payment on the 28th of May to €3.60...
Ny berättelse • Dec 05
Specialty Materials And Renewable Energy Initiatives Ignite Earnings Growth And Margin Expansion
Strategic projects and acquisitions aim to enhance Arkema's earnings growth and stability, leveraging mega trends in energy and healthcare.Fördelning av intäkter och kostnader
Fördelning av intäkter och kostnader
Hur Arkema tjänar och spenderar pengar. Baserat på senast rapporterade resultat, på rullande tolvmånadersbasis.
Resultat- och intäktshistorik
| Datum | Intäkter | Intäkter | G+A Kostnader | FoU-kostnader |
|---|---|---|---|---|
| 31 Mar 26 | 8,869 | 17 | 906 | 284 |
| 31 Dec 25 | 9,068 | 39 | 923 | 284 |
| 30 Sep 25 | 9,236 | 127 | 937 | 281 |
| 30 Jun 25 | 9,443 | 210 | 928 | 283 |
| 31 Mar 25 | 9,584 | 308 | 946 | 280 |
| 31 Dec 24 | 9,544 | 338 | 935 | 278 |
| 30 Sep 24 | 9,493 | 346 | 926 | 278 |
| 30 Jun 24 | 9,425 | 342 | 913 | 276 |
| 31 Mar 24 | 9,331 | 349 | 898 | 274 |
| 31 Dec 23 | 9,514 | 402 | 892 | 275 |
| 30 Sep 23 | 9,799 | 393 | 870 | 275 |
| 30 Jun 23 | 10,445 | 503 | 875 | 273 |
| 31 Mar 23 | 11,187 | 752 | 870 | 274 |
| 31 Dec 22 | 11,550 | 949 | 858 | 270 |
| 30 Sep 22 | 11,543 | 1,050 | 863 | 264 |
| 30 Jun 22 | 10,969 | 1,073 | 836 | 257 |
| 31 Mar 22 | 10,180 | 1,498 | 815 | 248 |
| 31 Dec 21 | 9,519 | 1,293 | 788 | 243 |
| 30 Sep 21 | 9,004 | 1,212 | 768 | 242 |
| 30 Jun 21 | 8,515 | 1,057 | 755 | 240 |
| 31 Mar 21 | 8,022 | 350 | 739 | 238 |
| 31 Dec 20 | 7,884 | 304 | 755 | 241 |
| 30 Sep 20 | 7,952 | 312 | 796 | 242 |
| 30 Jun 20 | 8,259 | 365 | 815 | 246 |
| 31 Mar 20 | 8,611 | 422 | 828 | 251 |
| 31 Dec 19 | 8,738 | 491 | 812 | 249 |
| 30 Sep 19 | 8,892 | 561 | 782 | 245 |
| 30 Jun 19 | 8,843 | 590 | 766 | 242 |
| 31 Mar 19 | 8,859 | 633 | 761 | 239 |
| 31 Dec 18 | 8,816 | 674 | 758 | 237 |
| 30 Sep 18 | 8,566 | 685 | 749 | 235 |
| 30 Jun 18 | 8,418 | 653 | 743 | 232 |
| 31 Mar 18 | 8,346 | 594 | 736 | 234 |
| 31 Dec 17 | 8,326 | 543 | 738 | 235 |
| 30 Sep 17 | 8,221 | 492 | 733 | 233 |
| 30 Jun 17 | 8,040 | 446 | 728 | 231 |
| 31 Mar 17 | 7,794 | 433 | 722 | 227 |
| 31 Dec 16 | 7,535 | 394 | 705 | 222 |
| 30 Sep 16 | 7,443 | 390 | 701 | 220 |
| 30 Jun 16 | 7,551 | 355 | 701 | 218 |
| 31 Mar 16 | 7,705 | 341 | 693 | 214 |
| 31 Dec 15 | 7,683 | 285 | 677 | 209 |
| 30 Sep 15 | 7,354 | 263 | 616 | 194 |
| 30 Jun 15 | 6,886 | 226 | 555 | 181 |
Kvalitetsintäkter: AKE har en stor engång förlust av €129.1M {1 månader till 31st March, 2026 1 månader) 31st March, 2026.
Växande vinstmarginal: AKE s nuvarande netto vinstmarginaler (0.2%) är lägre än förra året (3.2%).
Fritt kassaflöde vs resultatanalys
Analys av tidigare vinsttillväxt
Resultatutveckling: AKE s intäkter har minskat med 39% per år under de senaste 5 åren.
Accelererande tillväxt: AKE s har haft negativ intäktstillväxt under det senaste året, så det kan inte jämföras med dess 5-åriga genomsnitt.
Resultat vs industri: AKE hade negativ intäktstillväxt ( -94.5% ) under det senaste året, vilket gör det svårt att jämföra med branschens genomsnitt Chemicals ( 6.4% ).
Avkastning på eget kapital
Hög ROE: AKE s avkastning på eget kapital ( 0.6% ) anses vara låg.
Avkastning på tillgångar
Avkastning på sysselsatt kapital
Upptäck starka bolag som tidigare presterat bra
Företagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/05/20 15:14 |
| Aktiekurs vid dagens slut | 2026/05/20 00:00 |
| Intäkter | 2026/03/31 |
| Årlig intjäning | 2025/12/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
Arkema S.A. bevakas av 34 analytiker. 15 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| Gaurav Jain | Barclays |
| Katie Richards | Barclays |
| James Stewart | Barclays |